Browsing by Author Stordal, Britta

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2008A 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasomeDavey, Ross; Stordal, Britta; Northern Clinical School: Medicine; Medicine Faculty OfficeA 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasome, IUBMB Life, vol.60,(3),2008,pp 180-184
2009ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repairDavey, Ross; Stordal, Britta; Northern Clinical School: Medicine; Medicine Faculty OfficeERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair, Cancer Chemotherapy and Pharmacology, vol.63,(4),2009,pp 661-672
2007Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic reviewDavey, Ross; Pavlakis, Nick; Stordal, Britta; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty OfficeOxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review, Cancer Treatment Reviews, vol.33,(N/A),2007,pp 347-357
2005Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cellsDavey, Ross; Stordal, Britta; Davey, M. W.; Physics; Medicine Faculty OfficeOxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells, Cancer Chemotherapy and Pharmacology, vol.58,(2),2005,pp 256-265
2009Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrestDavey, Ross; Stordal, Britta; Northern Clinical School: Medicine; Medicine Faculty OfficeRegrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrest in Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, Humana Press, 2009, pp. 171-176
2006Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.Davey, Ross; Stordal, Britta; Peters, Greg; Physics; Medicine Faculty OfficeSimilar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance., Genes Chromosomes & Cancer, vol.45,(12),2006,pp 1094-1105
2009A systematic alalysis of oxaliplatin or paclitaxel salvage chemotherapyDavey, Ross; Pavlakis, Nick; Stordal, Britta; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty OfficeA systematic alalysis of oxaliplatin or paclitaxel salvage chemotherapy in Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, Humana Press, 2009, pp. 225-230
2009A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1.Davey, Ross; Stordal, Britta; Northern Clinical School: MedicineA systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1., Current Cancer Drug Targets, vol.9, 3,pp 354-365
2007A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationshipDavey, Ross; Pavlakis, Nick; Stordal, Britta; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty OfficeA systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship, Cancer Treatment Reviews, vol.33,(8),2007,pp 688-703